Nicola has over 20 years of experience with bacterial endotoxin testing and pharmaceutical microbiology. She has been involved in all aspects of the endotoxin assay, including the design and development of BET-specific instrumentation and software. Her work has led her to directing workshops and training courses, as well as lecturing internationally on a variety of BET-related topics including LAL methodologies, product validations, 21 CFR Part 11, and BET regulatory affairs.
- Webinar: Relying on Data: A Comparison of BET Methods
- Webinar: The Analytical Reality of Recombinant Endotoxin Technologies
- CleanRoom Technology: Charles River Laboratories updates microbial solutions portfolio
- BioPharma Asia: Regulatory Approval of Three Rapid Microbiological Methods for MACI Product Release